CTAS vs LEVI
Cintas Corp. and Levi Strauss & Co., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | CTAS | LEVI |
|---|---|---|
| Revenue | $11.3B | $6.3B |
| Net income | $2.0B | $578.1M |
| Gross margin | 50.7% | 61.7% |
| Net margin | 17.8% | 9.2% |
| Return on equity | 40.7% | 27.2% |
| Diluted EPS | $4.91 | $1.45 |
| Dividend / share | $1.80 | $0.54 |
| Payout ratio | 35.1% | 36.8% |
| Free cash flow | $1.9B | $308.2M |
| Equity | $5.1B | $2.3B |
| Net debt / equity | 0.42× | 0.12× |
| Current ratio | 1.43× | 1.55× |
| Revenue CAGR 5y | 9.6% | 7.1% |
| Profit CAGR 5y | 12.5% | — |
CTAS bills 1.8× the revenue of LEVI, and keeps more of each dollar of revenue as profit (17.8% against 9.2%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Revenue by year
10 years side by side
| Fiscal year | CTAS | LEVI |
|---|---|---|
| FY2025 | $11.3B | $6.3B |
| FY2024 | $10.3B | $6.0B |
| FY2023 | $9.6B | $5.8B |
| FY2022 | $8.8B | $6.2B |
| FY2021 | $7.9B | $5.8B |
| FY2020 | $7.1B | $4.5B |
| FY2019 | $7.1B | $5.8B |
| FY2018 | $6.9B | $5.6B |
| FY2017 | $6.5B | $4.9B |
| FY2016 | $5.3B | $4.6B |
Net income by year
Bottom line
| Fiscal year | CTAS | LEVI |
|---|---|---|
| FY2025 | $2.0B | $578.1M |
| FY2024 | $1.8B | $210.6M |
| FY2023 | $1.6B | $249.6M |
| FY2022 | $1.3B | $569.1M |
| FY2021 | $1.2B | $553.5M |
| FY2020 | $1.1B | $-127.1M |
| FY2019 | $876.0M | $394.6M |
| FY2018 | $885.0M | $283.1M |
| FY2017 | $842.6M | $281.4M |
| FY2016 | $480.7M | $291.1M |